Friday, October 30, 2026

Back to today

From X

@StableBread

Fajasy on X

By my numbers, Magna Mining $MGMNF (TSX: $NICU) is worth CAD$0.88-3.08/share before restart capital, depending mostly on Levack, its flagship mine. Here’s what the stock is worth under four Levack outcomes at Q2 margins, before restart capital (the upfront spending to rebuild and reopen the mine): 1) Levack worth nothing: CAD$0.88-1.09/share from cash, McCreedy West (the producing mine), and Crean Hill (the permitted nickel mine), 45-56% below the CAD$1.98 share price (October 23 close). 2) Levack at McCreedy West’s scale: 17M lbs/year is worth ~US$114M, which makes the stock worth CAD$1.35-1.56/share, 21-32% below CAD$1.98. 3) Levack at its study’s plan: The October 7 preliminary economic assessment (PEA) plans 36.8M lbs/year from mid-2028 to 2035, worth ~US$246M, which makes the stock worth CAD$1.90-2.12/share, 4% below to 7% above CAD$1.98. 4) Levack at the top of CEO Jason Jessup’s range (3x McCreedy West): 54M lbs/year is worth ~US$361M, which makes the stock worth ~CAD$2.59/share (+31%) with McCreedy West and Crean Hill at the top of my ranges. With a 10% higher realized price, Levack rises to ~US$479M and the stock to ~CAD$3.08 (+56%). The PEA’s CAD$70.1M of initial capital would take ~CAD$0.21/share off the last three cases, but pre-commercial cash flow and tax credits cut the net funding need to CAD$8.6M (~CAD$0.03/share). On the upside, SCP Resource Finance, a mining-focused investment bank, put a CAD$5.10 target on the stock (+158%) in its April 14 note, before Alpayana, a Peruvian mining group, bought 62.4M new shares at CAD$2.25. Canaccord Genuity $CCORF, a Canadian investment bank, and Desjardins, a Quebec-based financial cooperative, also cover the stock, and both advised Magna on the Alpayana deal. Reaching SCP’s CAD$5.10 would demand ~US$964M from Levack and the rest, ~3.9x Levack’s value at the PEA’s output and Q2 margins. Getting there takes (1) ore from R2, a high-grade zone at Levack, (2) higher metal prices, (3) better margins at Levack than at McCreedy West, or a strong mix of the three.

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.